ActiGraph

Measuring Critical Health Outcomes Beyond Weight Loss in GLP-1 and Related Obesity Treatments

New weight management medications, such as GLP-1 receptor agonists, have dramatically altered the...

Navigating the FDA DHT Guidance: Perspectives from Across the Industry

Digital health technologies (DHT) can collect objective, multi-dimensional data passively and...

Address Unmet Measurement Needs in Parkinson’s Disease with Wearable DHTs

Clinical development is a challenging task. Clinical development in Parkinson’s disease (PD) faces...

ActiGraph Announces Integration of Mobilise-D Algorithms in CentrePoint Platform

ActiGraph is excited to announce the integration of Mobilise-D algorithms for digital mobility...

Medical-Grade or Consumer Wearable? How to Choose

Since the late 1980s, wearable devices have helped researchers collect data on the physical...

The Vital Role of Clinical Research Sites in DHT Deployment

Once your team has made the decision to collect digital measures in your clinical trial and...

5 Important Questions to Ask Your Wearable Technology Partner

Wearable, sensor-based digital health technologies (DHTs) can provide clinical researchers with...

Why Prioritizing Patients Changes How Study Teams Approach DHTs

Although technology provides vast opportunities to improve clinical trial efficiency and unlock new...

Infographic: Digital Measures in Oncology Drug Development

Oncology is one of the most active and fastest growing areas of drug development research,...